jesus no im not wingnut yo. im just saying i understand.

New Post Public Reply Private Reply Replies (1) Message Board
seemingly-harmless Evil Rabbit #133598
757
jesus no im not wingnut yo.

im just saying i understand. its all old news anyway, the new crew has infinitely more talent to cross the finish line and my confidence is strong...finally.

but ive experinced similar retardation from silicon valley start up ceos i have worked for, so i have the palate to pull from. every start up ive worked for was destroyed by cocky clueless leadership, so investing here was a challenge, as it was obvious from day one nader was a car salesman at best. but he could raise tons of money so i was in.

i wanted leronlimab on the market saving lives before i invested. couldnt care less how that happened. i didnt have a side. but then it became overtly obvious that this is an investment of a lifetime - sir john templeton level opportunity

but then the idiots destroyed that didnt they.

too many here are upset that patterson took steps to control the drug, but forget the level of retardation he was dealing with. i mean endless high level immature inept chaos. the movie will be scrapped for a 10 episode netflix series in order to cover only half of the details. no one here can deny that.

again, im completely hosed and too far underwater to admit to anybody other than here...my people.

no one here has suggested what they would have done in his shoes. thats all.

lets hear it

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors Urged to Act as Lawsuit Against Everus Builds

Updated Category News Views 97

Investigation of Claims Against Everus Construction Group Faruqi & Faruqi, LLP, a well-respected national securities law firm, has initiated an investigation into potential claims associated with Everus Construction Group, Inc. (NYSE: ECG). The firm specializes in shareholder rights and is aiming to provide support to affected investors after concerning revelations about...

Continue Reading
Heilongjiang Forum 2025: Elevating Macao's Global Tourism Standing

Updated Category News Views 107

Global Tourism Economy Forum 2025: A Landmark Event The Global Tourism Economy Forum (GTEF) made its notable debut outside of Macao by hosting the 2025 edition in Heilongjiang province, China. This forum gathered influential figures from the tourism sector and various related industries, fostering discussions aimed at exploring new avenues for cooperation and growth....

Continue Reading
Nextracker and T1 Energy Collaboration Drives Solar Growth

Updated Category News Views 198

Nextracker and T1 Energy Join Forces to Strengthen Solar Production Nextracker Inc. (NASDAQ: NXT) has recently established a partnership with T1 Energy Inc. (NYSE: TE) aimed at revolutionizing solar manufacturing. This collaboration will see the integration of Nextracker's cutting-edge steel module frame technology into T1 Energy's upcoming solar manufacturing plant,...

Continue Reading
Nathan Ballentine Steps In as Regional VP at New American Funding

Updated Category News Views 175

New Leadership at New American Funding New American Funding (NAF), a prominent independent mortgage lender, has announced a significant appointment. Nathan Ballentine is joining the team as the Regional Vice President, where he will play a pivotal role in propelling growth and development within the state. His expertise will be crucial as the company seeks to deepen its...

Continue Reading
CSL Behring Secures Approval for ANDEMBRY® in Japan

Updated Category News Views 341

CSL Behring's Recent Approval for ANDEMBRY® CSL Behring has announced a significant medical milestone with the approval of ANDEMBRY® (garadacimab) subcutaneous (S.C.) injection 200mg pens in Japan. This groundbreaking therapy is a first-in-class monoclonal antibody specifically designed to inhibit activated Factor XII (FXIIa), a crucial initiator in the hereditary...

Continue Reading